Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award

Dr. Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award

Assistant Specialist at University of California Irvine Medical Center, United States

Dr. Fatemeh Tajik is an accomplished medical researcher dedicated to advancing cancer diagnostics. She earned her MD in 2021, ranking among the top 1% of her class. Since then, she has been engaged in groundbreaking research on cancer biomarkers, particularly circulating extracellular vesicle biomarkers for peritoneal carcinomatosis. Currently serving as an Assistant Specialist at the University of California, Irvine, Dr. Tajik contributes significantly to translational and clinical research, with the goal of improving patient outcomes.

Profile

ORCID

Education 🎓

Dr. Tajik completed her Doctor of Medicine (MD) in 2021. Her academic excellence placed her among the top 1% of her graduating class. Her advanced studies and research focus on cancer biomarker identification, leading to significant contributions in oncology.

Experience 🌟

From 2021 to 2023, Dr. Tajik dedicated her research to identifying novel cancer biomarkers, culminating in multiple peer-reviewed publications. In 2023, she joined the Department of Surgery at the University of California, Irvine, where she specializes in translational cancer research. Additionally, she serves as a reviewer for esteemed journals and has co-authored a book chapter, further demonstrating her expertise and commitment to the field.

Research Interests 🌿

Dr. Tajik’s research revolves around cancer biology, with a specific focus on:

  • Cancer biomarkers
  • Extracellular vesicles
  • Peritoneal carcinomatosis Her work aims to refine predictive and prognostic tools for cancer, significantly impacting early detection and treatment approaches.

Awards 🏆

Dr. Tajik has been recognized for her contributions to cancer research and innovation. She has been nominated for prestigious awards such as the Excellence in Research Award and the Best Researcher Award, highlighting her significant impact on the field.

Publications 📚

Dr. Tajik has published extensively in high-impact journals. Her notable publications include:

“Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis”

  • Journal: Cancers
  • Publication Date: January 17, 2025
  • DOI: 10.3390/cancers17020289

“Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease”

  • Journal: Journal of Gastrointestinal Cancer
  • Publication Date: June 2024
  • DOI: 10.1007/s12029-023-00994-5

“Transformation of Chronic Lymphocytic Leukemia into Acute Mixed Phenotype Leukemia Myeloid/T Neoplasm: a Case Report”

  • Journal: SN Comprehensive Clinical Medicine
  • Publication Date: September 11, 2023
  • DOI: 10.1007/s42399-023-01567-0

“Anxiety during the COVID-19 pandemic in hospital staff: systematic review plus meta-analysis”

  • Journal: BMJ Supportive & Palliative Care
  • Publication Date: June 2023
  • DOI: 10.1136/bmjspcare-2021-003125

“A comprehensive Examination of the potential application of Chat GPT in Higher Education Institutions”

  • Type: Preprint
  • Publication Date: April 12, 2023
  • DOI: 10.36227/techrxiv.22589497.v1

“Post-COVID-19 rhinocerebral mucormycosis, a life-threatening event in the background of immunosuppressive condition: A case report”

  • Type: Preprint
  • Publication Date: January 27, 2023
  • DOI: 10.21203/rs.3.rs-2516078/v1

“Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends”

  • Journal: Journal of Surgical Oncology
  • Publication Date: 2023
  • DOI: 10.1002/jso.27448

“Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis”

  • Journal: Cancer Cell International
  • Publication Date: 2023
  • DOI: 10.1186/s12935-023-02851-8

“Clinical significance of CD166 and HER-2 in different types of gastric cancer”

  • Journal: Clinical and Translational Oncology
  • Publication Date: 2023
  • DOI: 10.1007/s12094-023-03297-0

“COVID-19 pandemic impact on screening and diagnosis of prostate cancer: a systematic review”

  • Journal: BMJ Supportive and Palliative Care
  • Publication Date: 2023
  • DOI: 10.1136/spcare-2023-004310

Conclusion 🏅

Fatemeh Tajik is a highly qualified candidate for the Research for Cancer Biophotonics Award due to her impressive research output, strong academic background, and impactful work in cancer diagnostics. However, to make her application more competitive, she should highlight her direct contributions to biophotonics, expand her involvement in industry collaborations, and clearly outline her most significant scientific innovations.

 

Andrea Rodriguez Herrera | Imaging Technology Development | Bioimaging Advances Award

Dr.Andrea Rodriguez Herrera | Imaging Technology Development | Bioimaging Advances Award

Neurology resident at CMN November 20 ISSSTE CDMX, Mexico

Dr. Andrea Rodríguez Herrera is a dedicated neurology resident and researcher, affiliated with the National Autonomous University of Mexico (UNAM) and the prestigious ISSSTE’s CMN 20 de Noviembre. Her specialization spans neurophysiology and neuromuscular disorders, with a passion for clinical neurology, neuroscience education, and advancing treatment in neuromuscular diseases. Dr. Rodríguez has been a member of the International Parkinson and Movement Disorder Society since 2023 and actively contributes to various medical publications and societies.

Profile

Scopus

Strengths for the Award 🌟

Dr. Rodríguez has conducted significant research in neuromuscular diseases and cerebrovascular disorders, including her recent work on “Longitudinal Strain of the Left Atrium as a Predictor of Ischemic Stroke,” which has real potential to shape stroke prevention and patient care strategies.

Her clinical experience at ISSSTE’s CMN 20 de Noviembre and Ángeles Universidad Hospital, where she specializes in neurology and advanced neurophysiological procedures, complements her research work. This dual role as a researcher and clinician allows her to bring practical insights into her studies, making her research findings highly applicable and grounded in real-world challenges.

Her active participation in international conferences and memberships in societies like the American Academy of Neurology and the International Parkinson and Movement Disorder Society shows her engagement with the global research community. Her presence in these networks amplifies her research’s impact and promotes knowledge exchange across borders.

With several publications in prestigious journals such as Journal of the Neurological Sciences, her work has been cited in the field, demonstrating both its influence and relevance. Her recent studies address crucial topics such as SARS-CoV-2-related neurological impacts, which underscore her responsiveness to emerging medical challenges.

Education 🎓

Dr. Rodríguez Herrera has built an impressive educational foundation. She is currently a neurology resident at CMN 20 de Noviembre, ISSSTE, where she also conducts rotations in neuromuscular clinics and neurophysiology at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. She completed her internal medicine residency at Universidad La Salle and holds a background enriched by numerous certifications in advanced medical and neurological training.

Experience 💼

With a strong clinical and academic background, Dr. Rodríguez serves as a Neurology Resident at CMN 20 de Noviembre, ISSSTE, and as a physician at the Brain & Spine Clinic, Ángeles Universidad Hospital in Mexico City. She also teaches neuroscience and has been part of editorial boards, reviewing articles for prominent journals in neurology and internal medicine. Her role extends to being a valuable reviewer for the Journal of Neurology, Neurological Science and Disorders, and Annals of Clinical Endocrinology and Metabolism, among others. Dr. Rodríguez’s clinical expertise includes specialized knowledge in transcranial doppler procedures and vascular neurology.

Research Interests 🔬

Dr. Rodríguez’s research interests focus on neuromuscular diseases, vascular neurology, and cerebrovascular disorders. Her recent studies include evaluating the “Longitudinal Strain of the Left Atrium as a Predictor of Ischemic Stroke” at Médica Sur Hospital, reflecting her commitment to advancing stroke prevention and neurological health. She is also a member of the RENAMEVASC research group, contributing to vascular disease insights.

Awards and Recognition 🏆

Dr. Rodríguez has been recognized for her dedication and expertise through her memberships in the American Academy of Neurology and the International Parkinson and Movement Disorder Society. She actively participates in international conferences, presenting posters and sharing case studies on neurodegenerative diseases, such as at the World Congress of Neurology. These accolades underscore her commitment to staying at the forefront of neurology.

Publications 📚

Dr. Rodríguez has published extensively in high-impact journals, contributing to our understanding of neurological and cerebrovascular conditions. Here are some of her notable publications:

Pioneering Augmented and Mixed Reality in Cranial Surgery: The First Latin American Experience

  • Authors: Ramírez Romero, A., Rodríguez Herrera, A.R., Sánchez Cuellar, J.F., Cevallos Delgado, R.E., Ochoa Martínez, E.E.
  • Journal: Brain Sciences
  • Year: 2024
  • Volume/Issue: 14(10)
  • Article Number: 1025
  • Citations: 0

Cerebral Hemodynamics in the Non-Alcoholic Fatty Liver

  • Authors: Vidal-González, D., López-Sánchez, G.N., Concha-Rebollar, L.A., Nader-Kawachi, J.A., Nuño-Lámbarri, N.
  • Journal: Annals of Hepatology
  • Year: 2020
  • Volume/Issue: 19(6)
  • Pages: 668–673
  • Citations: 3

Conclusion 💡

Dr. Andrea Rodríguez Herrera embodies the qualities of a top-tier researcher, bringing a unique blend of clinical insight, research acumen, and a commitment to advancing knowledge in neurology. Her contributions have made a tangible impact on the understanding and treatment of neuromuscular and cerebrovascular disorders, and her research is distinguished by its clinical relevance and responsiveness to contemporary health challenges. With continued growth in cross-disciplinary research and mentorship roles, Dr. Rodríguez is well-positioned to make even greater contributions to the medical community. She is a remarkable candidate for the Research for Best Researcher Award, and her achievements and potential make her an ideal nominee for this recognition.